Release Date: 20/04/16 17:27 Summary: Amend 01/04/2016 Header from Company Secretary to Director-SIE.AX Price Sensitive: No Download Document 148.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%